Lambda interferon
Showing 1 - 25 of 1,694
Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)
Completed
- Liver Disease
- Hepatitis D
- Peg-interferon lambda
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 6, 2021
COVID-19, COVID Trial in Boston (Pegylated interferon lambda)
Terminated
- COVID-19
- COVID
- Pegylated interferon lambda
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)
Completed
- Hepatitis D, Chronic
- Peginterferon Lambda-1A
-
Beersheba, Israel
- +3 more
Dec 20, 2022
COVID-19 Trial in Be'er Sheva (Lambda 180 mcg S.C)
Recruiting
- COVID-19
- Lambda 180 mcg S.C
-
Be'er Sheva, IsraelSoroka UMC
Jan 27, 2022
Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )
Recruiting
- Sars-CoV2
- Covid-19
- Peginterferon Lambda-1A
- placebo
-
Botucatu, Brazil
- +6 more
Jan 17, 2022
Hepatitis Delta Virus Trial in Worldwide (Peginterferon Lambda-1a)
Recruiting
- Hepatitis Delta Virus
- Peginterferon Lambda-1a
-
Los Angeles, California
- +61 more
Jan 30, 2023
Covid19, SARS-Associated Coronavirus Trial in Brazil (Fluvoxamine Maleate 100 MG [Luvox], Budesonide Powder, Placebo (mild
Recruiting
- Covid19
- SARS-Associated Coronavirus
- Fluvoxamine Maleate 100 MG [Luvox]
- +4 more
-
Betim, MG, Brazil
- +11 more
Jul 3, 2022
Sars-CoV-2 Infection Trial in Baltimore (Peginterferon lambda alfa-1a subcutaneous injection, Saline)
Terminated
- Sars-CoV-2 Infection
- Peginterferon lambda alfa-1a subcutaneous injection
- Saline
-
Baltimore, MarylandJohns Hopkins Hospital
Jul 12, 2022
Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)
Active, not recruiting
- Sars-CoV2
- Covid19
- Peginterferon Lambda-1A
- Placebo
-
Toronto, Ontario, CanadaToronto General Hospital
Apr 4, 2022
Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon
Not yet recruiting
- Chronic Hepatitis Delta
- Peginterferon Lambda
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 25, 2023
Hepatitis C Virus Trial in Worldwide (Pegylated-Interferon-lambda, Ribavirin, Daclatasvir)
Completed
- Hepatitis C Virus
- Pegylated-Interferon-lambda
- +2 more
-
Palo Alto, California
- +31 more
Aug 7, 2020
COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)
Recruiting
- COVID-19
- Children
- Inhaled Interferon α2b
- Standard of Care
-
Shanghai, ChinaChildren Hospital of Fudan University
May 18, 2022
Study of the Angle Lambda and Ocular Dominance
Recruiting
- No Eye Disorder
- Eye examination
-
Paris, FranceHôpital Necker-Enfants Malades
Jan 16, 2023
Cytomegalovirus Reactivation in Non Immunocompromised Patients
Completed
- Cardiac Surgery
- Blood test
-
Beer Sheva, IsraelSoroka University Medical Center
Oct 24, 2022
MRD Detection by NGS in Pediatric B-ALL
Completed
- Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
- MRD
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
s of Kappa and Lambda Free Light Chains in Central Nervous
Completed
- Central Nervous System Diseases
- Multiple Sclerosis
- Biological collection
-
Clermont-Ferrand, France
- +13 more
Nov 8, 2021
Lung Transplant Rejection Trial (Prospera)
Not yet recruiting
- Lung Transplant Rejection
- Prospera
- (no location specified)
Jan 3, 2022
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
Recruiting
- AIDS
- Hepatitis B
- Peginterferon alfa-2b Injection
-
Guangzhou, Guangdong, ChinaGuangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023
COVID-19 Trial in Stanford (Peginterferon Lambda-1a, Placebo)
Completed
- COVID-19
- Peginterferon Lambda-1a
- Placebo
-
Stanford, CaliforniaStanford University School of Medicine
Nov 24, 2021
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United
Active, not recruiting
- Metastatic Cutaneous Melanoma
- +15 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +582 more
Jan 28, 2023
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023